ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 224 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.68 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,422 | -13.0% | 740 | 0.0% | 0.00% | -50.0% |
| Q2 2023 | $17,723 | +27.3% | 740 | 0.0% | 0.00% | +100.0% |
| Q1 2023 | $13,927 | +18.2% | 740 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $11,781 | -1.8% | 740 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $12,000 | +20.0% | 740 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $10,000 | -44.4% | 740 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $18,000 | +5.9% | 740 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $17,000 | +41.7% | 740 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $12,000 | -33.3% | 740 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $18,000 | -5.3% | 740 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $19,000 | -57.8% | 740 | -12.9% | 0.00% | -75.0% |
| Q4 2020 | $45,000 | +45.2% | 850 | +14.9% | 0.00% | +33.3% |
| Q3 2020 | $31,000 | -13.9% | 740 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $36,000 | +16.1% | 740 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $31,000 | -3.1% | 740 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $32,000 | +18.5% | 740 | -3.1% | 0.00% | +50.0% |
| Q3 2019 | $27,000 | – | 764 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 28,439,114 | $590,396,000 | 3.89% |
| GREAT POINT PARTNERS LLC | 1,196,098 | $24,831,000 | 3.87% |
| EMORY UNIVERSITY | 196,601 | $4,081,000 | 2.67% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| NEXTHERA CAPITAL LP | 500,000 | $10,380,000 | 1.99% |
| Palo Alto Investors LP | 1,684,180 | $34,964,000 | 1.41% |
| Opus Point Partners Management, LLC | 20,828 | $432,000 | 1.03% |
| Opaleye Management Inc. | 195,000 | $4,048,000 | 1.03% |
| GARRISON BRADFORD & ASSOCIATES INC | 48,500 | $1,007,000 | 0.81% |